In addition to the pro-tumor effects of S100A8 when expressed in cancer cells which, in BC, so far have mostly been linked to transformation, invasion and migration [15–17], it is thought to contribute further to cancer progression through its association with a loosely defined class of immune-suppressive myeloid cells. Here, S100A8 is linked to breast cancer.